Olprinone

DB16847InvestigationalSmall molecule

Olprinone: Overview.

Mechanism: Pharmacologically active on cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A and Phosphodiesterase 3
Curator reviewed
Formula / weight: C₁₄H₁₀N₄O · 250.261 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyJPAWFIIYTJQOKW-UHFFFAOYSA-NSMILESCC1=C(C=C(C#N)C(=O)N1)C1=CN2C=CN=C2C=C1

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Olprinone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.